Skip to content

A prospective study on the effect of different antiosteoporosis drugs on patients after lumbar fusion surgery

A prospective study on the effect of different antiosteoporosis drugs on patients after lumbar fusion surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016968
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-07-15
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis with lumbar spinal stenosis

Interventions

C:Lumbar Fusion Surgery+Basic anti-osteoporosis drugs
A:Lumbar Fusion Surgery+MenatetrenoneSoft Capsules
B:Lumbar Fusion Surgery+Teriparatide acetate

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients of osteoporosis with lumbar spinal stenosis

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating woman; 2. Patients with serious cardial, hepatic or renal disease; 3. Patients having envolved in another clinical trials; 4. Patients don't want to attend this research or observe the blind method of this research; 5. Patients unsuitable for this trial for other reasons evaluated by researchers.

Design outcomes

Primary

MeasureTime frame
Japanese orthopeadic association score;Bone mineral density;Lumbar CT;

Secondary

MeasureTime frame
Visual analogue scale;The oswestry disability index;VIT-D;N-MIDOs;ß-CROSS;T-P1NP;UCOC;Lumbar X-ray;

Countries

China

Contacts

Public ContactHaipeng Si

Qilu Hospital of Shandong University

18560082571@163.com+86 18560082571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026